- About Us
- Nano-Social Network
- Nano Consulting
- My Account
May 8th, 2006
NanoNovus: May 8
Jack Uldrich: This article from the Miami Herald provides a good overview of nanotechnology’s ability (and limitations) to detect cancer at an early stage. On the positive side, nanotechnology is leading to the development and creation of new diagnostic technologies that can detect unique “biomarkers”–specific proteins that show up when a cancer is present.
On the down side, these biomarkers are not always either sensitive or specific to a single disease. This suggests that even if new diagnostic technologies are developed, they might not do that much good.
|Related News Press|
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017